Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension.
Badagliacca R, Raina A, Ghio S, D'Alto M, Confalonieri M, Correale M, Corda M, Paciocco G, Lombardi C, Mulè M, Poscia R, Scelsi L, Argiento P, Sciomer S, Benza RL, Vizza CD. Badagliacca R, et al. Among authors: confalonieri m. J Heart Lung Transplant. 2018 Mar;37(3):365-375. doi: 10.1016/j.healun.2017.08.009. Epub 2017 Aug 26. J Heart Lung Transplant. 2018. PMID: 28912026 Free article.
Bosentan for patients with chronic thromboembolic pulmonary hypertension.
Vassallo FG, Kodric M, Scarduelli C, Harari S, Potena A, Scarda A, Piattella M, Cassandro R, Confalonieri M. Vassallo FG, et al. Among authors: confalonieri m. Eur J Intern Med. 2009 Jan;20(1):24-9. doi: 10.1016/j.ejim.2008.03.008. Epub 2008 Apr 29. Eur J Intern Med. 2009. PMID: 19237088 Clinical Trial.
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.
Vitulo P, Stanziola A, Confalonieri M, Libertucci D, Oggionni T, Rottoli P, Paciocco G, Tuzzolino F, Martino L, Beretta M, Callari A, Amaducci A, Badagliacca R, Poscia R, Meloni F, Refini RM, Geri P, Baldi S, Ghio S, D'Alto M, Argiento P, Sofia M, Guardamagna M, Pezzuto B, Vizza CD. Vitulo P, et al. Among authors: confalonieri m. J Heart Lung Transplant. 2017 Feb;36(2):166-174. doi: 10.1016/j.healun.2016.04.010. Epub 2016 May 7. J Heart Lung Transplant. 2017. PMID: 27329400 Free article. Clinical Trial.
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
Badagliacca R, D'Alto M, Ghio S, Argiento P, Bellomo V, Brunetti ND, Casu G, Confalonieri M, Corda M, Correale M, D'Agostino C, De Michele L, Galgano G, Greco A, Lombardi C, Manzi G, Mercurio V, Mulè M, Paciocco G, Papa S, Romeo E, Scelsi L, Stolfo D, Vitulo P, Naeije R, Vizza CD. Badagliacca R, et al. Among authors: confalonieri m. Am J Respir Crit Care Med. 2021 Feb 15;203(4):484-492. doi: 10.1164/rccm.202004-1006OC. Am J Respir Crit Care Med. 2021. PMID: 32857597
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
Badagliacca R, Papa S, D'Alto M, Ghio S, Agostoni P, Ameri P, Argiento P, Brunetti ND, Casamassima V, Casu G, Cedrone N, Confalonieri M, Corda M, Correale M, D'Agostino C, De Michele L, Famoso G, Galgano G, Greco A, Lombardi CM, Manzi G, Madonna R, Mercurio V, Mulè M, Paciocco G, Romaniello A, Romeo E, Scelsi L, Serra W, Stolfo D, Toma M, Vatrano M, Vitulo P, Vizza CD; italian Pulmonary Hypertension NETwork (iPHNET). Badagliacca R, et al. Among authors: confalonieri m. Eur Respir J. 2022 Oct 6;60(4):2102276. doi: 10.1183/13993003.02276-2021. Print 2022 Oct. Eur Respir J. 2022. PMID: 35301247 Free PMC article.
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension.
Badagliacca R, D'Alto M, Ghio S, Argiento P, Brunetti ND, Casu G, Cedrone N, Confalonieri M, Corda M, Correale M, D'Agostino C, De Michele L, Di Marino S, Filomena D, Galgano G, Greco A, Lombardi C, Manzi G, Mercurio V, Mulè M, Paciocco G, Papa S, Romeo E, Scelsi L, Stolfo D, Vitulo P, Vizza CD. Badagliacca R, et al. Among authors: confalonieri m. ERJ Open Res. 2022 Nov 7;8(4):00298-2022. doi: 10.1183/23120541.00298-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36382240 Free PMC article.
Left Heart Disease Phenotype in Elderly Patients with Pulmonary Arterial Hypertension: Insights from the Italian PATRIARCA Registry.
Toma M, Miceli R, Bonsante E, Colombo D, Confalonieri M, Garascia A, Ghio S, Lattanzio M, Lombardi CM, Paciocco G, Piccinino C, Rota I, Santolamazza C, Scelsi L, Scuri P, Stolfo D, Vincenzi A, Volpiano L, Vicenzi M, Ameri P. Toma M, et al. Among authors: confalonieri m. J Clin Med. 2022 Nov 30;11(23):7136. doi: 10.3390/jcm11237136. J Clin Med. 2022. PMID: 36498710 Free PMC article.
Bosentan for chronic thromboembolic pulmonary hypertension.
Confalonieri M, Kodric M, Longo C, Vassallo FG. Confalonieri M, et al. Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1503-12. doi: 10.1586/erc.09.148. Expert Rev Cardiovasc Ther. 2009. PMID: 19954311 Review.
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.
Harari S, Caminati A, Albera C, Vancheri C, Poletti V, Pesci A, Luppi F, Saltini C, Agostini C, Bargagli E, Sebastiani A, Sanduzzi A, Giunta V, Della Porta R, Bandelli GP, Puglisi S, Tomassetti S, Biffi A, Cerri S, Mari A, Cinetto F, Tirelli F, Farinelli G, Bocchino M, Specchia C, Confalonieri M. Harari S, et al. Among authors: confalonieri m. Respir Med. 2015 Jul;109(7):904-13. doi: 10.1016/j.rmed.2015.04.010. Epub 2015 Apr 25. Respir Med. 2015. PMID: 25962649 Free article.
297 results